Literature DB >> 20431967

The prognostic significance of heart rate for cardiovascular disease and hypertension.

Trygve B Tjugen1, Arnljot Flaa, Sverre E Kjeldsen.   

Abstract

Five decades ago, hypertension was a debated risk factor for the development of cardiovascular disease. After further studies and the introduction of antihypertensive medications, few, if any, have doubted the important role hypertension plays as a cardiovascular risk factor. Today, a growing body of evidence emphasizes the relationship between heart rate and hypertension, and heart rate and cardiovascular disease, which makes the measurement of heart rate an important component of the cardiovascular risk assessment. Current European guidelines for managing arterial hypertension recommend the measurement of heart rate for risk stratification, but there still are no recommendations for treatment. This review discusses the evidence for a relationship between heart rate and cardiovascular mortality and morbidity and hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431967     DOI: 10.1007/s11906-010-0104-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  41 in total

1.  Changes of cardiac output in hypertensive disease.

Authors:  J WIDIMSKY; M H FEJFAROVA; Z FEJFAR
Journal:  Cardiologia       Date:  1957

2.  The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study)

Authors:  E Kristal-Boneh; H Silber; G Harari; P Froom
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

3.  Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure.

Authors:  A Benetos; A Rudnichi; F Thomas; M Safar; L Guize
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

4.  Relationship between cardiac output and peripheral resistance in borderline hypertension.

Authors:  S Julius; A V Pascual; R Sannerstedt; C Mitchell
Journal:  Circulation       Date:  1971-03       Impact factor: 29.690

5.  Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension.

Authors:  S E Kjeldsen; N J Schork; P Leren; I K Eide
Journal:  Am Heart J       Date:  1989-10       Impact factor: 4.749

6.  Hemodynamic predictors of incident hypertension. The Framingham Heart Study.

Authors:  W S Post; M G Larson; D Levy
Journal:  Hypertension       Date:  1994-11       Impact factor: 10.190

Review 7.  Are vascular abnormalities a primary cause or secondary consequence of hypertension?

Authors:  M J Mulvany
Journal:  Hypertension       Date:  1991-09       Impact factor: 10.190

8.  Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines.

Authors:  F H Messerli; E D Frohlich; D H Suarez; E Reisin; G R Dreslinski; F G Dunn; F E Cole
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

9.  Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study.

Authors:  R F Gillum; D M Makuc; J J Feldman
Journal:  Am Heart J       Date:  1991-01       Impact factor: 4.749

10.  Relationship of blood pressure in 20-39-year-old men to subsequent blood pressure and incidence of hypertension over a 30-year observation period.

Authors:  S W Rabkin; F A Mathewson; R B Tate
Journal:  Circulation       Date:  1982-02       Impact factor: 29.690

View more
  9 in total

Review 1.  Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction.

Authors:  Karl-Erik Andersson; Lysanne Campeau; Brian Olshansky
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

2.  AGT M235T genotype/anxiety interaction and gender in the HyperGEN study.

Authors:  Sarah S Knox; Xinxin Guo; Yuqing Zhang; G Weidner; Scott Williams; R Curtis Ellison
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

3.  Nocturnal pulse rate correlated with ambulatory blood pressure and target organ damage in patients with chronic kidney disease.

Authors:  Jun Zhang; Ruowei Wen; Jinmei Yin; Ye Zhu; Lin Lin; Zengchun Ye; Hui Peng; Cheng Wang; Tanqi Lou
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-31       Impact factor: 3.738

4.  Simultaneous parasympathetic and sympathetic activation reveals altered autonomic control of heart rate, vascular tension, and epinephrine release in anesthetized hypertensive rats.

Authors:  Torill Berg; Jørgen Jensen
Journal:  Front Neurol       Date:  2011-11-23       Impact factor: 4.003

5.  The combined dexamethasone/TSST paradigm--a new method for psychoneuroendocrinology.

Authors:  Julie Andrews; Catherine D'Aguiar; Jens C Pruessner
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

6.  Voltage-Sensitive K(+) Channels Inhibit Parasympathetic Ganglion Transmission and Vagal Control of Heart Rate in Hypertensive Rats.

Authors:  Torill Berg
Journal:  Front Neurol       Date:  2015-12-08       Impact factor: 4.003

7.  Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.

Authors:  Qingxia Du; Yongchang Sun; Ning Ding; Lijin Lu; Ying Chen
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

Review 8.  The Kv7 Channel and Cardiovascular Risk Factors.

Authors:  Andreas L Fosmo; Øyvind B Skraastad
Journal:  Front Cardiovasc Med       Date:  2017-12-05

9.  Blood Pressure, Heart Rate, and CNS Stimulant Medication Use in Children with and without ADHD: Analysis of NHANES Data.

Authors:  Susan M Hailpern; Brent M Egan; Kimberly D Lewis; Carol Wagner; Ghassan F Shattat; Doaa I Al Qaoud; Ibrahim F Shatat
Journal:  Front Pediatr       Date:  2014-09-19       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.